resveratrol has been researched along with Neointima in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Haase, T; Kamann, S; Löchel, M; Peters-Berg, D; Schnorr, J; Schütt, D; Stolzenburg, N | 1 |
| Breen, DM; Dalvi, PS; Dolinsky, VW; Giacca, A; Gonzalez Medina, M; Guo, J; Heximer, SP; McBurney, MW; McCole, DF; Mori, Y; Pereira, TJ; Tsiani, EL; Zhang, H | 1 |
| Cheng, C; Huang, Q; Lin, X; Liu, B; Liu, S; Luo, C; Mo, P; Ou, W; Zhong, J | 1 |
| Bettink, S; Clever, YP; Häckel, A; Kamann, S; Löchel, M; Peters, D; Schellenberger, E; Scheller, B; Speck, U; Trog, S | 1 |
| Czernizer, E; Dardik, A; Dardik, H; Hoffmann, T; London, D; Naftalovich, R; Orozco-Sevilla, V; Yang, C | 1 |
| Chen, J; Guo, Q; Hu, Q; Jiang, H; Xu, C; Yang, J; Zhang, J | 1 |
| Abud, B; Albayrak, G; Aykut, K; Ergür, BU; Karaarslan, K; Silistreli, E | 1 |
| Albertini, M; Calvillo, L; Casana, R; Cilurzo, F; Mazzola, S; Selmin, F; Tolva, V; Zerbi, P | 1 |
| Campagnolo, P; di Bernardini, E; Hong, X; Hu, Y; Smyrnias, I; Xu, Q | 1 |
| Kang, KW; Kim, JW; Kim, SK; Lee, JW; Lee, MY; Lim, SC; Oh, WK | 1 |
| Dugas, TR; Foley, JD; Kleinedler, JJ; Orchard, EA | 1 |
| Bendeck, MP; Breen, DM; Dandona, P; Dolinsky, VW; Dyck, JR; Ghanim, H; Giacca, A; Guo, J; Heximer, SP; Mroziewicz, M; Tsiani, EL; Zhang, H | 1 |
| Asmis, R; Dugas, TR; Hebert, VY; Khandelwal, AR; Kleinedler, JJ; Rogers, LK; Shi, R; Ullevig, SL | 1 |
13 other study(ies) available for resveratrol and Neointima
| Article | Year |
|---|---|
Bare Metal Stents on Resveratrol-Coated Balloons in Porcine Coronary and Peripheral Arteries.
Topics: Angioplasty, Balloon; Animals; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Equipment Design; Feasibility Studies; Fibrin; Neointima; Resveratrol; Swine; Vasa Vasorum; Wound Healing | 2021 |
Resveratrol Inhibits Neointimal Growth after Arterial Injury in High-Fat-Fed Rodents: The Roles of SIRT1 and AMPK.
Topics: AMP-Activated Protein Kinases; Animals; Carotid Artery Injuries; Carotid Artery, Common; Diet, High-Fat; Disease Models, Animal; Femoral Artery; Insulin Resistance; Mice, Knockout; Neointima; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Sirtuin 1; Vascular System Injuries | 2020 |
Resveratrol inhibits angiotensin II‑induced proliferation of A7r5 cells and decreases neointimal hyperplasia by inhibiting the CaMKII‑HDAC4 signaling pathway.
Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Cycle; Cell Line; Histone Deacetylases; Hyperplasia; Male; Neointima; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes | 2018 |
Drug Distribution and Basic Pharmacology of Paclitaxel/Resveratrol-Coated Balloon Catheters.
Topics: Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Animals; Coated Materials, Biocompatible; In Vitro Techniques; Neointima; Paclitaxel; Resveratrol; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stilbenes; Swine | 2018 |
Epigallocatechin-3-gallate is a potent phytochemical inhibitor of intimal hyperplasia in the wire-injured carotid artery.
Topics: Animals; Cardiovascular Agents; Carotid Artery Injuries; Carotid Artery, Common; Carotid Intima-Media Thickness; Catechin; Cell Proliferation; Disease Models, Animal; Disulfides; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hyperplasia; Injections, Intraperitoneal; Isothiocyanates; Male; Neointima; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Sulfinic Acids; Sulfoxides; Time Factors | 2013 |
Resveratrol inhibits phenotypic switching of neointimal vascular smooth muscle cells after balloon injury through blockade of Notch pathway.
Topics: Animals; Antioxidants; Aorta, Thoracic; Carotid Arteries; Carotid Artery Injuries; Cells, Cultured; Disease Models, Animal; Hyperplasia; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Rats; Rats, Sprague-Dawley; Receptor, Notch1; Resveratrol; Stilbenes; Time Factors | 2014 |
The effect of resveratrol on intimal hyperplasia and endothelial proliferation of rabbit carotid artery anastomosis.
Topics: Anastomosis, Surgical; Animals; Carotid Arteries; Carotid Intima-Media Thickness; Cell Proliferation; Endothelial Cells; Hyperplasia; Male; Models, Animal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Rabbits; Resveratrol; Stilbenes; Time Factors | 2015 |
A successful experimental model for intimal hyperplasia prevention using a resveratrol-delivering balloon.
Topics: Angioplasty, Balloon; Animals; Cardiovascular Agents; Cell Proliferation; Cells, Cultured; Coated Materials, Biocompatible; Disease Models, Animal; Equipment Design; Humans; Hyperplasia; Iliac Artery; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Rabbits; Resveratrol; Stilbenes; Vascular Access Devices; Vascular System Injuries | 2016 |
Resveratrol-Induced Vascular Progenitor Differentiation towards Endothelial Lineage via MiR-21/Akt/β-Catenin Is Protective in Vessel Graft Models.
Topics: Animals; beta Catenin; Biomarkers; Blood Vessels; Cell Differentiation; Cell Line; Embryonic Stem Cells; Endothelial Cells; Gene Expression; Mice; MicroRNAs; Neointima; Proto-Oncogene Proteins c-akt; Resveratrol; Stem Cells; Stilbenes; Transplants | 2015 |
Inhibition of neointimal formation by trans-resveratrol: role of phosphatidyl inositol 3-kinase-dependent Nrf2 activation in heme oxygenase-1 induction.
Topics: Animals; Aorta, Thoracic; Arterial Occlusive Diseases; Cell Line; Cell Nucleus; Cell Proliferation; Cells, Cultured; Cyclin D; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Femoral Artery; Heme Oxygenase-1; Hyperplasia; Membrane Proteins; Mice; Muscle, Smooth, Vascular; Neointima; NF-E2-Related Factor 2; Phosphoinositide-3 Kinase Inhibitors; Protein Transport; Rats; Reactive Oxygen Species; Resveratrol; Retinoblastoma Protein; Stilbenes | 2010 |
Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization.
Topics: Angioplasty; Animals; Antimitotic Agents; Cell Proliferation; Constriction, Pathologic; Drug-Eluting Stents; Endothelium, Vascular; Female; Hyperplasia; Male; Nanocomposites; Neointima; Quercetin; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2012 |
Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism.
Topics: Administration, Oral; Animals; Aorta; Cardiovascular Agents; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Disease Models, Animal; Enzyme Inhibitors; Femoral Artery; Gene Expression Regulation; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Neointima; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes; Time Factors; Vascular System Injuries | 2012 |
Resveratrol and quercetin interact to inhibit neointimal hyperplasia in mice with a carotid injury.
Topics: Animals; Antioxidants; Carotid Artery Injuries; Cell Proliferation; Chemotaxis; Drug Interactions; Endothelial Cells; Endothelium, Vascular; Female; Hyperplasia; Inflammation; Mice; Monocytes; Neointima; Quercetin; Resveratrol; Stilbenes; Thromboxane B2 | 2012 |